Previous studies on the pathogenesis of acute renal failure have demonstrated that NF-κB inhibitors can significantly reduce the production of IL-1β and IL-18 in albumin-stimulated HK-2 cells [29]. The gene discussed is NFKB1; the disease is acute kidney injury.